Interactive forest plots for Covid-19
The COVID-NMA initiative. A living mapping and living systematic review of Covid-19 trials
Select a comparison
Lopinavir-Ritonavir vs Standard Care
Umifenovir vs Standard Care
Hydroxychloroquine vs Standard Care/Placebo
Lopinavir-Ritonavir vs Umifenovir
Favipiravir vs Umifenovir
Novaferon+Lopinavir-Ritonavir vs Lopinavir-Ritonavir
Novaferon+Lopinavir-Ritonavir vs Novaferon
Novaferon vs Lopinavir-Ritonavir
Remdesivir vs Standard Care/Placebo
Convalescent plasma vs Standard care/Placebo
Interferon beta vs Standard Care
Tocilizumab vs Standard Care/Placebo
HCQ+AZM vs Hydroxychloroquine
HCQ+AZM vs Standard care/Placebo
Intravenous Immunoglobulin vs Standard Care
Ivermectin vs Standard care
Corticosteroids vs Standard Care/Placebo
Favipiravir 1800/800mg vs Favipiravir 1600/600mg
Favipiravir vs Standard Care
Sofosbuvir+Daclatasvir vs Standard Care
Nitazoxanide vs Placebo
IVM+DX vs Placebo
Hydroxychloroquine vs Azithromycin
Peginterferon Lambda-1a vs Placebo
Hydroxychloroquine+Zinc vs Hydroxychloroquine
SNG001 vs Placebo
Vitamin D vs Standard care/Placebo
Select an outcome
Clinical improvement D7
Clinical improvement D14-D28
Clinical improvement D60
WHO Score 6 D7
WHO Score 6 D14-D28
WHO Score 7 D7
WHO Score 7 D14-D28
Mortality D7
Mortality D14-D28
Mortality D60
Mortality D90
Negative conversion D3
Negative conversion D7
Adverse events
Serious adverse events
Time to clinincal improvement
Time to WHO score 6
Time to WHO score 7
Time to death
Time to Negative Conversion
Type of analysis
Random-effects
Fixed-effects
Exclude High RoB studies
No
Yes
Severity of population
All population
Mild population
Mixed population
Critical population
Align RoB
Reset
Download Forest plot
